S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Stoke Therapeutics (STOK) Insider Trading & Ownership

$11.65
-0.07 (-0.60%)
(As of 04/18/2024 ET)

Stoke Therapeutics (NASDAQ:STOK) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
12.30%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$42.89 M
Get STOK Insider Trade Alerts

Want to know when executives and insiders are buying or selling Stoke Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

STOK Insider Buying and Selling by Quarter

Stoke Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/17/2024Skorpios TrustMajor ShareholderSell3,600,000$11.60$41,760,000.00  
3/28/2024Jonathan AllanGeneral CounselSell5,126$13.20$67,663.20  
3/19/2024Edward M Md KayeCEOSell11,150$6.10$68,015.00  
3/19/2024Jonathan AllanGeneral CounselSell2,349$6.10$14,328.90  
3/19/2024Stephen J TulipanoCFOSell4,116$6.10$25,107.60  
2/1/2024Barry TichoInsiderSell10,000$4.80$48,000.00  
1/2/2024Barry TichoInsiderSell10,000$5.74$57,400.00  
7/3/2023Barry TichoInsiderSell15,000$10.60$159,000.00  
6/21/2023Jonathan AllanGeneral CounselSell1,948$13.48$26,259.04  
6/1/2023Barry TichoInsiderSell15,000$11.13$166,950.00  
5/3/2023Barry TichoInsiderSell24,697$10.14$250,427.58  
5/1/2023Barry TichoInsiderSell24,967$10.00$249,670.00  
(Data available from 1/1/2013 forward)

STOK Insider Trading Activity - Frequently Asked Questions

Who is on Stoke Therapeutics's Insider Roster?

The list of insiders at Stoke Therapeutics includes Barry Ticho, Edward M Md Kaye, Huw M Nash, Jonathan Allan, Skorpios Trust, and Stephen J Tulipano. Learn more on insiders at STOK.

What percentage of Stoke Therapeutics stock is owned by insiders?

12.30% of Stoke Therapeutics stock is owned by insiders. Learn more on STOK's insider holdings.

Which Stoke Therapeutics insiders have been selling company stock?

The following insiders have sold STOK shares in the last 24 months: Barry Ticho ($1,028,652.28), Edward M Md Kaye ($68,015.00), Jonathan Allan ($108,251.14), Skorpios Trust ($41,760,000.00), and Stephen J Tulipano ($25,107.60).

How much insider selling is happening at Stoke Therapeutics?

Insiders have sold a total of 3,734,055 Stoke Therapeutics shares in the last 24 months for a total of $42,990,026.02 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:STOK) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners